Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17175
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chia, Puey Ling | - |
dc.contributor.author | John, Thomas | - |
dc.date.accessioned | 2018-02-22T01:10:02Z | - |
dc.date.available | 2018-02-22T01:10:02Z | - |
dc.date.issued | 2016-06 | - |
dc.identifier.citation | Journal of immunotherapy 2016; 39(5): 202-204 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/17175 | - |
dc.description.abstract | Immunomodulatory agents that target PD-1 and its ligand (PD-L1) are being increasingly used in the management of lung cancer. Potential immune-related adverse events include dermatological complications which mostly are of low grade severity. The use of immune checkpoint inhibitors may lead to the exacerbation of autoimmune conditions. We report a case of a documented psoriasis flare with anti-PD-1 treatment for lung cancer. | - |
dc.language.iso | eng | - |
dc.title | Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC). | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Journal of immunotherapy | - |
dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Victoria, Australia | en |
dc.identifier.affiliation | Department of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre, Heidelberg, Victoria, Australia | - |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | - |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/27163740 | - |
dc.identifier.doi | 10.1097/CJI.0000000000000121 | - |
dc.identifier.pubmedid | 27163740 | - |
dc.type.austin | Case Reports | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Chia, Puey Ling | |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.